The Parker Institute for Cancer Immunotherapy enables real collaboration, accelerating ambitious research to deliver new immunotherapies engineered to save lives.
World-renowned experts from leading cancer centers are at the forefront of our research.
Our model allows us to work with top talent across disciplines beyond our six centers.
Open in Twitter Parker Institute @parkerici RT @statnews: The hope and hurdles of CAR-T https://t.co/ApxfISAbLg 🔒 https://t.co/93BbHuShQL 2 days ago
Open in Twitter Parker Institute @parkerici RT @UCSFCancer: Immune-Cell Numbers Predict Response to Combo #Immunotherapy in #Melanoma @ad1600 @katyktsai https://t.co/IH4Ly2C91p @parke… 3 days ago